Related Experiment Video
Updated: Feb 3, 2026

A Preclinical Murine Model of Hepatic Metastases
Published on: September 27, 2014
New horizons in hepatitis B and C in the older adult
Linda Kemp1, Kathleen E Clare1, Paul N Brennan1
1Gut Group, Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical school, Dundee, UK.
Insights
Hepatitis C (HCV) and Hepatitis B (HBV) infections are increasing in older adults. New therapies now offer a cure for HCV and effective control for HBV, improving patient outcomes.
Area of Science:
- Hepatology
- Infectious Diseases
- Epidemiology
Background:
- Hepatitis C (HCV) and Hepatitis B (HBV) are blood-borne viruses causing acute hepatitis.
- Chronic infection with HCV and HBV is linked to cirrhosis and liver cancer.
- These viral infections are increasingly prevalent in older populations due to past exposure risks.
Purpose of the Study:
- To review the natural history and epidemiology of HCV and HBV infections.
- To discuss advancements in antiviral therapies for HCV and HBV.
- To highlight the current treatment landscape for these chronic viral infections.
Main Methods:
- Literature review of epidemiological data on HCV and HBV.
- Analysis of current therapeutic strategies for HCV and HBV.
- Synthesis of information on disease progression and management.
Main Results:
- HCV and HBV infections pose significant risks for chronic liver disease, including cirrhosis and hepatocellular carcinoma.
- Risk factors such as intravenous drug use, multiple sexual partners, and men who have sex with men contribute to transmission.
- Recent therapeutic revolutions enable HCV cure and complete control of HBV infection.
Conclusions:
- Effective treatments are now available for both HCV and HBV, transforming patient management.
- Understanding the epidemiology and natural history is crucial for targeting interventions in aging populations.
- The advent of curative and controllable therapies marks a new era in managing viral hepatitis.
Abstract:
Hepatitis C (HCV) and hepatitis B (HBV), are blood-borne viruses that can cause acute hepatitis; but are clinically relevant because chronic infection is associated with development of cirrhosis and hepatocellular carcinoma. Both these viruses are becoming more common in the older population, due to the ageing of generations exposed to the risk factors associated with infection; intravenous drug use, multiple sexual partners and men who have sex with men. This review will cover the natural history and epidemiology of these infections as well as the revolution in drug therapy that now allows cure of HCV infection and complete control of HBV infection.
Related Concept Videos
Schwarzschild Radius and Event Horizon
The minimum speed required to launch a projectile from the surface of an object to which it is gravitationally bound so that it eventually escapes the object’s gravitational field is called the escape velocity. The escape velocity is independent of the mass of the object. Merging the idea of escape...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Adult Stem Cells
Hepatic Drug Excretion: Influencing Factors

